Correlation Between Milestone Pharmaceuticals and Cadrenal Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Cadrenal Therapeutics,.
Diversification Opportunities for Milestone Pharmaceuticals and Cadrenal Therapeutics,
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Milestone and Cadrenal is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Cadrenal Therapeutics, go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Cadrenal Therapeutics,
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Cadrenal Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Milestone Pharmaceuticals is 10.71 times less risky than Cadrenal Therapeutics,. The stock trades about -0.01 of its potential returns per unit of risk. The Cadrenal Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 0.15 in Cadrenal Therapeutics, Common on August 30, 2024 and sell it today you would earn a total of 1,415 from holding Cadrenal Therapeutics, Common or generate 943233.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 94.76% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Cadrenal Therapeutics, Common
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Cadrenal Therapeutics, |
Milestone Pharmaceuticals and Cadrenal Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Cadrenal Therapeutics,
The main advantage of trading using opposite Milestone Pharmaceuticals and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.The idea behind Milestone Pharmaceuticals and Cadrenal Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |